Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity.
暂无分享,去创建一个
[1] L. S. Pontryagin,et al. Mathematical Theory of Optimal Processes , 1962 .
[2] Richard Bellman,et al. Introduction to the mathematical theory of control processes , 1967 .
[3] L. Norton,et al. Tumor size, sensitivity to therapy, and design of treatment schedules. , 1977, Cancer treatment reports.
[4] J. Goldie,et al. A model for the resistance of tumor cells to cancer chemotherapeutic agents , 1983 .
[5] L. Norton,et al. The Norton-Simon hypothesis revisited. , 1986, Cancer treatment reports.
[6] L. Wein,et al. Optimal scheduling of radiotherapy and angiogenic inhibitors , 2003, Bulletin of mathematical biology.
[7] J. Goldie. Drug Resistance in Cancer: A Perspective , 2004, Cancer and Metastasis Reviews.
[8] U. Ledzewicz,et al. The influence of pk/pd on the structure of optimal controls in cancer chemotherapy models. , 2005, Mathematical biosciences and engineering : MBE.
[9] M. Chyba,et al. Singular Trajectories and Their Role in Control Theory , 2003, IEEE Transactions on Automatic Control.
[10] I. Tannock,et al. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.
[11] Jr-Shin Li,et al. Ensemble control of linear systems , 2007, 2007 46th IEEE Conference on Decision and Control.
[12] Urszula Ledzewicz,et al. AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem , 2007, SIAM J. Control. Optim..
[13] Jr-Shin Li,et al. Ensemble Control of Bloch Equations , 2009, IEEE Transactions on Automatic Control.
[14] Urszula Ledzewicz,et al. No . 4 B Singular controls and chattering arcs in optimal control problems arising in biomedicine , 2010 .
[15] R. Gatenby. A change of strategy in the war on cancer , 2009, Nature.
[16] Nicolas André,et al. Metronomic chemotherapy: new rationale for new directions , 2010, Nature Reviews Clinical Oncology.
[17] Urszula Ledzewicz,et al. Minimizing Tumor Volume for a Mathematical Model of Anti-Angiogenesis with Linear Pharmacokinetics , 2010 .
[18] Nicolas André,et al. Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy? , 2011, Future oncology.
[19] B. Perthame,et al. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies , 2012, 1207.0923.
[20] H. Schättler,et al. Geometric Optimal Control , 2012 .
[21] H. Schättler,et al. Geometric Optimal Control: Theory, Methods and Examples , 2012 .
[22] M. Gottesman,et al. The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance , 2013 .
[23] M. Gottesman,et al. The Impact of Cell Density and Mutations in a Model of Multidrug Resistance in Solid Tumors , 2014, Bulletin of Mathematical Biology.
[24] B. Perthame,et al. Modeling the Effects of Space Structure and Combination Therapies on Phenotypic Heterogeneity and Drug Resistance in Solid Tumors , 2014, Bulletin of Mathematical Biology.
[25] Urszula Ledzewicz,et al. Optimal Control for Mathematical Models of Cancer Therapies: An Application of Geometric Methods , 2015 .